Prevalence and clinical implications of cyclin D1 expression in diffuse large B‐cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab‐CHOP Consortium Program
Chi Young Ok(The University of Texas MD Anderson Cancer Center), Ken H. Young(Duke Medical Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Maurilio Ponzoni(San Raffaele University of Rome), Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Zijun Y. Xu‐Monette(Duke University), Attilio Orazi(Texas Tech University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Kristy L. Richards(University of North Carolina at Chapel Hill), Youli Zu(Methodist Hospital), John P. Farnen(Gundersen Health System), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Santiago Montes‐Moreno(Universidad de Cantabria), L. Jeffrey Medeiros(Delaware Division of Libraries), Dennis P. O’Malley(Ambry Genetics (United States)), Jane N. Winter(Northwestern University)
Cited by 45
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k